Alfano, Franco
Bigoni, Tommaso
Caggiano, Francesco Paolo
Papi, Alberto http://orcid.org/0000-0002-6924-4500
Funding for this research was provided by:
Università degli Studi di Ferrara
Article History
Accepted: 19 April 2024
First Online: 7 May 2024
Declarations
:
: All authors contributed to literature review and data evaluation. AP prepared the first draft of manuscript. All authors critically revised and contributed to the finalization of the manuscript. All authors read and approved the final version of the manuscript.
: Open access funding provided by Università degli Studi di Ferrara within the CRUI-CARE Agreement.
: Not applicable.
: AP received grants for research from Chiesi, Astrazeneca, GSK, and Sanofi; consulting fees or advisory board fees from Chiesi, Astrazeneca, GSK, Mundipharma, Novartis, Edmond, Sanofi, Avillion, IQVIA, Elpen Pharmaceuticals, TEVA, and MSD, and lecture fees form Chiesi, Astrazeneca, GSK, Mundipharma, Sanofi, MSD, Novartis, and Zambon outside the submitted work. FA, TB, and FPC have nothing to disclose.
: Not applicable
: Not applicable